VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Universe Pharmaceuticals Inc. (UPC) Total Return Calculator with Dividends Reinvested

Universe Pharmaceuticals Inc.

Popular:

The total return for Universe Pharmaceuticals Inc. (UPC) stock is -36.87% over the past 12 months. So far it's down 32.17% this year. The 5-year total return is -99.98%, meaning $10,000 invested in UPC stock 5 years ago would be worth $2 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in UPC 1 year ago, it would be worth $5,544 today — you'd have lost $4,456.

With Dividends Reinvested$5,544-44.56%

Price Only (No DRIP)$5,544-44.56%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in UPC

1Y$6,313-$3,687 (-36.9%)-36.9% CAGR

3Y$12-$9,988 (-99.9%)-89.5% CAGR

5Y$2-$9,998 (-100.0%)-81.0% CAGR

10Y$2-$9,998 (-100.0%)-58.1% CAGR

15Y$2-$9,998 (-100.0%)-44.0% CAGR

20Y$2-$9,998 (-100.0%)-35.3% CAGR

30Y$2-$9,998 (-100.0%)-25.2% CAGR

Universe Pharmaceuticals Inc. did not pay dividends during this period. Total return = price return.

Loading UPC total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-32.17%	—	-32.17%	—	$6,783
1Y	-36.87%	-36.87%	-36.87%	—	$6,313
3Y	-99.88%	-89.51%	-99.88%	—	$12
5Y	-99.98%	-81.02%	-99.98%	—	$2
10Y	-99.98%	-58.14%	-99.98%	—	$2
15Y	-99.98%	-44.05%	-99.98%	—	$2
20Y	-99.98%	-35.30%	-99.98%	—	$2
30Y	-99.98%	-25.20%	-99.98%	—	$2

Risk & Highlights

Best Year-18.54%2022

Worst Year-97.84%2024

Max Drawdown-76.24%2025-10-08 → 2026-03-25

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-34.62%	-34.62%	—	+0.41%	-35.0pp
2025	-85.20%	-85.20%	—	+16.64%	-101.8pp
2024	-97.84%	-97.84%	—	+24.00%	-121.8pp
2023	-78.91%	-78.91%	—	+24.81%	-103.7pp
2022	-18.54%	-18.54%	—	-19.95%	+1.4pp

UPC underperformed the S&P 500 by 68.20pp over the past year (-36.87% vs +31.32%).

Loading summary...

UPC Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
UPCUniverse Pharmaceuticals Inc.	$2M	-3.7%	-32.2%	-36.9%	—	-99.9%	-100.0%	-100.0%
HCWBHCW Biologics Inc.	$14M	+22.0%	-68.7%	-94.8%	—	-99.4%	-99.9%	-99.9%
XTLBXTL Biopharmaceuticals Ltd.	$357,581	+30.5%	+35.4%	-43.6%	—	-33.9%	-76.3%	-84.5%
NUVBNuvation Bio Inc.	$1.7B	+13.3%	-41.3%	+141.1%	—	+211.1%	-54.3%	-49.6%
CPRXCatalyst Pharmaceuticals, Inc.	$3.7B	+22.2%	+31.8%	+32.4%	—	+75.7%	+553.5%	+4915.6%
TLPHTalphera, Inc.	$43M	+19.0%	-25.0%	+61.2%	—	+17.6%	-96.2%	-98.7%
SIGASIGA Technologies, Inc.	$337M	-9.6%	-15.5%	+0.6%	+11.4pp	+21.7%	+1.0%	+722.2%
HROWHarrow Health, Inc.	$1.5B	+14.6%	-19.3%	+67.0%	—	+47.5%	+389.3%	+988.4%
MCKMcKesson Corporation	$91.1B	-13.2%	-9.6%	+5.0%	+0.4pp	+104.0%	+308.4%	+351.9%
CAHCardinal Health, Inc.	$45.1B	-9.9%	-6.4%	+27.6%	+1.3pp	+134.8%	+256.4%	+174.5%
HSICHenry Schein, Inc.	$8.3B	-3.2%	-5.7%	+9.4%	—	-9.2%	-9.4%	+8.7%

Compare:UPC vs HCWB UPC vs XTLB UPC vs NUVB UPC vs HCWB vs XTLB

About UPC Dividend Returns

Universe Pharmaceuticals Inc. (UPC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of UPC over the past year?

Universe Pharmaceuticals Inc. (UPC) delivered a return of -36.87% over the past year. Since UPC does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in UPC be worth today?

A $10,000 investment in Universe Pharmaceuticals Inc. one year ago would be worth $6,313 today, representing a loss of $3,687.

Q3Does UPC pay dividends?

Universe Pharmaceuticals Inc. (UPC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For UPC, the total return equals the price-only return.

Q4Did UPC beat the S&P 500?

No, Universe Pharmaceuticals Inc. (UPC) underperformed the S&P 500 by 68.20 percentage points over the past year. UPC delivered a total return of -36.87%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed UPC by 68.20pp during this period.

Q5What is UPC's worst drawdown?

Universe Pharmaceuticals Inc. (UPC) experienced a maximum drawdown of -76.24% over the past year, declining from its peak on 2025-10-08 to its trough on 2026-03-25. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is UPC's long-term total return over 10, 20, or 30 years?

Here are Universe Pharmaceuticals Inc. (UPC)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-58.1% CAGR) — $10,000 would have grown to $2. Over 20 years: -100.0% total return (-35.3% CAGR) — $10,000 → $2. Over 30 years: -100.0% total return (-25.2% CAGR) — $10,000 → $2. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was UPC's best and worst year?

Universe Pharmaceuticals Inc.'s best calendar year was 2022 with a total return of -18.5%. Its worst year was 2024 with a total return of -97.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 79.3 percentage points.